Galen Lab Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Galen Lab Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Secondary Activities: Pharmacies and Drug Stores | Other Direct Selling Establishments | Engineering Services | Research and Development in Biotechnology (except Nanobiotechnology) | All Other Professional, Scientific, and Technical Services | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | Offices of Physicians | All Other Miscellaneous Ambulatory Health Care Services

Full name: Galen Lab Sp. z o.o.

Profile Updated: May 17, 2024

Galen Lab Sp. z o.o. is an enterprise located in Poland, with the main office in Bierun. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on March 02, 2018. The latest financial highlights indicate a net sales revenue increase of 1314.14% in 2023. There was a total growth of 61.55% in Galen Lab Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Jerzego 6
Bierun; Slaskie; Postal Code: 43-150

Contact Details: Purchase the Galen Lab Sp. z o.o. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Galen Lab Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Galen Lab Sp. z o.o. report to view the information.

Incorporation Date:

March 02, 2018

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

91%

Company Performance

Financial values in the chart are available after Galen Lab Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

1314.14%▲

Total operating revenue

1314.14%▲

Operating profit (EBIT)

N/A

Net Profit (Loss) for the Period

N/A

Total assets

61.55%▲

Total equity

58.52%▲

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Quick Ratio

-19.03%▼

Similar companies